leadf
logo-loader
viewMagicMed Industries Inc

MagicMed CEO and Experts talks Patents in the Psychedelics Sector

MagicMed Industries (CSE: MGIC reserved) CEO Dr. Joseph Tucker joined Steve Darling from Proactive along with Intellectual Property expert Dr. Harm Deckers and MagicMed's Chief Technology Officer Dr. Jillian Hagel to discuss Patents and protecting intellectual property within the Psychadelics sector.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MagicMed Industries Inc named herein, including the promotion by the Company of MagicMed Industries Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

MagicMed completes patent portfolio of their Psybrary while launching...

MagicMed Industries CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company completed the development of their psilocybin-derivatives patent portfolio which they call “The Psybrary” Tucker says the Psybrary is a collection of novel psychedelic-derivative drug...

on 22/12/20

2 min read